Clinical data | |
---|---|
Other names | Burefrine; Phenylephrine oxazolidine; Phenylephrine oxazolidine prodrug |
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C14H21NO2 |
Molar mass | 235.327 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Berefrine (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name), also known as burefrine, is a sympathomimetic and mydriatic medication that was never marketed. It is described as an oxazolidine prodrug of phenylephrine and hence would act as a selective α1-adrenergic receptor agonist.
See also
References
- Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 615–. ISBN 978-0-412-46630-4.
- World Health Organization (2000). International Nonproprietary Names (INN) for Pharmaceutical Substances. World Health Organization. ISBN 978-0-11-986227-0.
- "3-(2-Tert-butyl-3-methyl-1,3-oxazolidin-5-yl)phenol". PubChem. Retrieved 31 August 2024.
This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |